Worth reading
48Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
19
%Wording
Conditional
How definitive the wording is.Results for this period
First quarter1 April 2026 to 30 June 2026ConsolidatedIFRSNet Sales18,885¥ millionYear on year +19.0%Progress 23.1%
Operating profit1,606¥ millionYear on year +26.4%Progress 19.6%
Ordinary income1,622¥ millionYear on year +26.9%Progress 19.6%
Net income attributable to owners of the parent1,060¥ millionYear on year +24.3%Progress 19.7%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share¥26.39
Financial position at period-end
Total assets122,995¥ million
of which net assets 32,837 ¥ millionEquity ratio 21.4%vs. prior year-end -0.3pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Cash and cash equivalents at end of period¥31,078,330 thousand
Segment revenue
Information Infrastructure Business13,90573.6%+20.9%
Application and Services Business2,57413.6%+11.8%
Medical Systems Business2,40512.7%+16.7%
Segment profit
Information Infrastructure Business1,49293.0%+19.1%
Application and Services Business472.9%
Medical Systems Business664.1%+6.2%
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥81,800 million (YoY +14.0%)
Operating profit¥8,200 million (YoY +5.7%)
Ordinary income¥8,280 million (YoY +5.3%)
Net income¥5,380 million (YoY +3.9%)
Revision to Earnings ForecastNo
Annual Dividend Forecast¥52 → ¥54
Factors Behind Changes in Business Performance
Revenue and operating profit increased due to growing demand, particularly for cloud-based security products, new and renewal orders, the accumulation of subscription revenue, and increased sales of cloud-based products. The Company also incurred higher selling, general and administrative expenses and made investments in product development, marketing and additional personnel.
Disclosure regarding the going concern assumption
No applicable matters.
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 Not disclosed
Changes in the scope of consolidationNew Number of companies 1 / Company name Medmain Co., Ltd. / Excluded Number of companies 0 / Company name Not disclosed
Material subsequent eventsAt a meeting of the Board of Directors held on 31 July 2026, the Company resolved to acquire up to 2,300,000 treasury shares for a total acquisition price of up to ¥3.2 billion and to cancel all acquired shares on 31 March 2027.
Depreciation and amortization¥760,776 thousand
Orders received and order backlogOrders received ¥22,913 million / Order backlog ¥109,545 million / By segment Information Infrastructure Business Orders received ¥16,253 million / Order backlog ¥81,229 million / Application and Services Business Orders received ¥3,686 million / Order backlog ¥8,237 million / Medical Systems Business Orders received ¥2,973 million / Order backlog ¥20,077 million
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingWhether applicable No / Subject person Not disclosed
Issued Shares at Period-End44,518,400
Treasury Shares at Period-End4,329,352
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | IFRS |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026 to 30 June 2026 |
| Net Sales | ¥18,885 million (YoY +19.0%) |
| Operating profit | ¥1,606 million (YoY +26.4%) |
| Ordinary income | ¥1,622 million (YoY +26.9%) |
| Profit attributable to owners of the parent | ¥1,060 million (YoY +24.3%) |
| Net income per share | ¥26.39 |
| Equity ratio | End of the current fiscal period 21.4 / End of previous period 21.7 |
| Total assets | ¥122,995 million |
| Net assets | ¥32,837 million |
| Cash and cash equivalents at end of period | ¥31,078,330 thousand |
| Full-year earnings forecast | Net Sales ¥81,800 million (YoY +14.0%) / Operating profit ¥8,200 million (YoY +5.7%) / Ordinary income ¥8,280 million (YoY +5.3%) / Net income ¥5,380 million (YoY +3.9%) |
| Revision to Earnings Forecast | No |
| Annual Dividend Forecast | ¥52 → ¥54 |
| Segment revenue | Information Infrastructure Business ¥13,905 million (YoY +20.9%) / Application and Services Business ¥2,574 million (YoY +11.8%) / Medical Systems Business ¥2,405 million (YoY +16.7%) |
| Segment profit | Information Infrastructure Business ¥1,492 million (YoY +19.1%) / Application and Services Business ¥47 million / Medical Systems Business ¥66 million (YoY +6.2%) |
| Orders received and order backlog | Orders received ¥22,913 million / Order backlog ¥109,545 million / By segment Information Infrastructure Business Orders received ¥16,253 million / Order backlog ¥81,229 million / Application and Services Business Orders received ¥3,686 million / Order backlog ¥8,237 million / Medical Systems Business Orders received ¥2,973 million / Order backlog ¥20,077 million |
| Depreciation and amortization | ¥760,776 thousand |
| Disclosure regarding the going concern assumption | No applicable matters. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement Not disclosed |
| Changes in the scope of consolidation | New Number of companies 1 / Company name Medmain Co., Ltd. / Excluded Number of companies 0 / Company name Not disclosed |
| Material subsequent events | At a meeting of the Board of Directors held on 31 July 2026, the Company resolved to acquire up to 2,300,000 treasury shares for a total acquisition price of up to ¥3.2 billion and to cancel all acquired shares on 31 March 2027. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable No / Subject person Not disclosed |
| Issued Shares at Period-End | 44,518,400 |
| Treasury Shares at Period-End | 4,329,352 |
| Factors Behind Changes in Business Performance | Revenue and operating profit increased due to growing demand, particularly for cloud-based security products, new and renewal orders, the accumulation of subscription revenue, and increased sales of cloud-based products. The Company also incurred higher selling, general and administrative expenses and made investments in product development, marketing and additional personnel. |
Items this document does not state (9)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesPayout ratioShareholder Return PolicyRegional salesImpairment lossBreakdown of extraordinary income (loss)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue increased due to growing demand, particularly for cloud-based security products, new and renewal orders, the accumulation of subscription revenue, and increased sales of cloud-based products. Selling, general and administrative expenses and investments in product development, marketing and other areas also increased, but were absorbed by business growth and improved profitability.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.